CLINICAL_TRIALS
ClinicalTrials.gov record update
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07488572
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:10.152215+00:00
- Published At
- 2026-03-23T00:00:00+00:00
- Record Updated At
- 2026-03-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Renal Cell Carcinoma (RCC)", "Metastatic Clear Cell Renal Cell Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-23"- protocolSection.identificationModule.nctId
"NCT07488572"- protocolSection.identificationModule.officialTitle
"Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study"- protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.